The Hidden Truth About the FDA’s New Legal Draft: Your Supplements Could Become Big Pharma Drugs

Why we must stop Congress from approving the FDASLA

In a new discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act FDA is seeking to expand its control over dietary supplements.

Because the supplement market is poorly-regulated and needs reform, you might initially think the new discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act is an improvement. The Senate HELP Committee even outlines the benefits of the discussion draft in an appealing yet misleading frame, stating that it will increase market competition to lower drug prices.

However, there’s more than meets the eye; this draft is not about improving public safety; its most glaring concern is about power and market control, simply disguised as an effort to improve consumer safety.

In fact, by requiring mandatory product listing, this draft would give the FDA the power to remove supplements at its discretion without any scientific basis. It would have the authority to take supplements away from the public and small businesses, then hand them over to Big Pharma to monopolize. Since lists of the supposed “benefits” of this draft abound, here are some of the overlooked ways this…